Hypermethylated WASF2: tumor suppressive role in head and neck squamous cell carcinoma

Jianyun Zhang1, Zhuang Ding1, Long Chen1

  • 1Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.

Abstract

Insights

Hypermethylated WASF2 acts as a tumor suppressor in head and neck squamous cell carcinoma (HNSCC). DNA methylation inhibits WASF2 expression, impacting tumor formation and immune response in HNSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genomics

Background:

  • The protein WASF2 is crucial for actin reorganization and cell migration.
  • WASF2's role in gastric, breast, and pancreatic cancers is established, but its mechanisms and function in head and neck squamous cell carcinoma (HNSCC) are unknown.
  • Investigating DNA methylation's effect on WASF2 expression in HNSCC is essential.

Purpose of the Study:

  • To examine the impact of DNA methylation on aberrant WASF2 expression in HNSCC.
  • To analyze the expression, function, and prognostic value of WASF2 in HNSCC.
  • To explore the correlation between WASF2, immune cell infiltration, and methylation in HNSCC.

Main Methods:

  • Utilized TNMplot, TIMER, GSEA, and Kaplan-Meier Plotter for expression and prognostic analysis.
  • Assessed WASF2 promoter methylation and its correlation with expression using the DNMIVD database.
  • Analyzed the effect of DNA methylation inhibitors on WASF2 expression via the GEO database and investigated immune relationships using TISIDB.

Main Results:

  • WASF2 was significantly downregulated in HNSCC with elevated promoter methylation.
  • DNA methylation inhibitor treatment restored WASF2 mRNA expression, indicating a regulatory role for methylation.
  • WASF2 expression served as a favorable prognostic indicator in HPV-positive HNSCC, with promoter methylation negatively impacting survival.

Conclusions:

  • Hypermethylated WASF2 functions as a tumor suppressor in HNSCC.
  • WASF2 regulates tumor formation and immune imbalance in HNSCC.
  • Restored WASF2 expression through methylation inhibition presents a potential therapeutic avenue.